Shockwave Medical Inc (SWAV)
329.99
-0.20
(-0.06%)
USD |
NASDAQ |
May 01, 16:00
329.04
-0.95
(-0.29%)
After-Hours: 20:00
Shockwave Medical Accounts Receivable (Quarterly): 114.55M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 114.55M |
September 30, 2023 | 98.82M |
June 30, 2023 | 96.56M |
March 31, 2023 | 84.31M |
December 31, 2022 | 71.37M |
September 30, 2022 | 64.22M |
June 30, 2022 | 59.80M |
March 31, 2022 | 47.84M |
December 31, 2021 | 37.44M |
September 30, 2021 | 29.97M |
June 30, 2021 | 24.96M |
Date | Value |
---|---|
March 31, 2021 | 19.61M |
December 31, 2020 | 11.69M |
September 30, 2020 | 10.71M |
June 30, 2020 | 6.365M |
March 31, 2020 | 7.811M |
December 31, 2019 | 7.377M |
September 30, 2019 | 5.551M |
June 30, 2019 | 5.242M |
March 31, 2019 | 3.939M |
December 31, 2018 | 2.85M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
5.242M
Minimum
Jun 2019
114.55M
Maximum
Dec 2023
42.33M
Average
29.97M
Median
Sep 2021
Accounts Receivable (Quarterly) Benchmarks
Boston Scientific Corp | 2.228B |
AtriCure Inc | 52.50M |
Masimo Corp | 355.50M |
Perspective Therapeutics Inc | 1.165M |
Xtant Medical Holdings Inc | 20.73M |